Stock data

科妍 (1786)

科妍 is a TWSE-listed company in Biotech & Medical Care. Revenue for September 2026 was NT$61.10M, up 1.3% from a year earlier. EPS over the last four quarters totals NT$2.43.

Charts, drawing tools, and the P/E calculator are in the app, free to use.

Open 科妍 in Insightr